Market News

8 min read | Updated on May 14, 2026, 08:14 IST
SUMMARY
Stocks to watch: Stocks such as Balrampur Chini Mills, Shree Renuka Sugars, and Triveni Engineering & Industries, among others, are expected to remain in focus after the government on Wednesday banned sugar exports with immediate effect till September 30, 2026, or until further orders, as India seeks to curb domestic prices.

The GIFT NIFTY futures suggest that the NIFTY50 index will open 69 points higher. Image: Shutterstock
The move is likely to support global raw and white sugar prices, while creating an opportunity for rival producers such as Brazil and Thailand to increase shipments to buyers across Asia and Africa.
In the corresponding period of the previous fiscal year, it had logged a profit of ₹11,021.8 crore, according to a regulatory filing.
However, its revenue from operations increased 15.68% YoY to ₹55,383.2 crore during the quarter under review, compared with ₹47,876.2 crore in the March quarter of the 2024-25 fiscal year (Q4 FY25).
Its top line grew on the back of sustained growth in India and robust performance in Africa.
The company's revenue from operations jumped 22% on a year-on-year (YoY) basis to ₹24,452 crore in the January to March quarter, as against ₹19,999 crore seen in Q4 FY25.
The auto major’s operating profit, also known as earnings before interest, taxes, depreciation, and amortisation (EBITDA), surged 36% to ₹3,307 crore as against ₹2,438 crore in the corresponding period last year.
The state-run company reported a 62% jump in consolidated fourth quarter profit (Q4 FY26), helped by higher crude oil production and improved price realisation.
The explorer posted a consolidated profit after tax (PAT) of ₹2,424 crore for Q4 FY26, compared with ₹1,497 crore a year earlier, the company said in a statement.
Further, OIL achieved a standalone PAT of ₹1,790 crore in Q4 FY26 against ₹1,591 crore logged in Q4 FY25.
The Q4 profit rise was supported by a 6% increase in crude oil production and higher crude price realisation at $77.89 per barrel versus $74.46 per barrel in the year-ago quarter.
Full-year consolidated profit rose to ₹7,551 crore from ₹7,040 crore registered in FY25.
The company had posted a profit of about ₹468.4 crore in the same period a year ago.
The company accounted for a charge of ₹24.6 crore during the quarter under review.
In a regulatory filing, the firm stated that the charge -- which relates to government-mandated fees or duties -- was partially offset by a ₹5.5-crore tax benefit. The net impact of this adjustment on the company's bottom line for the quarter, hence, stands at ₹19.1 crore, it said.
The company's revenue from operations increased 5.4% to ₹2,413.7 crore in Q4, as compared to ₹2,289 crore in Q4 FY25.
Seen sequentially, Bharti Hexacom's profit fell 5.7% while revenue rose 2.3%.
The company had reported a PAT (profit after tax) of ₹10.71 crore in the year-ago period, according to a statement.
Consolidated revenue of ₹256.29 crore in the fourth quarter of FY26 was up 26% compared to ₹203.11 crore in the same quarter of the preceding fiscal.
For the full 2025-26 fiscal, consolidated revenue rose by over 20% to ₹1,078.41 crore against ₹895.53 crore in FY25.
Net profit for the full fiscal year was up by 37% at ₹64.30 crore against ₹46.82 crore seen in FY25. EBITDA (earnings before interest, taxes, and amortisation) stood at ₹121.88 crore with a margin of 29.08%.
Zydus Worldwide DMCC, a subsidiary of the company, has signed a definitive agreement through its wholly-owned acquisition arm. Zara Merger Sub Inc., with Assertio Holdings Inc., to acquire all outstanding shares of Assertio for $23.50 per share in cash, Zydus Lifesciences Ltd said in a statement.
It represents total consideration of approximately $166.4 million on a fully diluted basis, calculated using the treasury stock method, it added.
Assertio is a US-based pharmaceutical company focused on speciality and oncology supportive care therapies.
The acquisition provides Zydus with an established US speciality oncology commercial platform, anchored by Assertio's presence in oncology supportive care, the statement said.
The company had posted a consolidated net profit of ₹481.96 crore in the year-ago period.
The total income of the PSU rose to ₹5,197.22 crore from over ₹3,971.90 crore in the year-ago period, NLC India said in a filing to the BSE.
The total expenses of the PSU increased to ₹4,327.14 crore from over ₹3,880.46 crore in the year-ago period.
The company said its board approved the final dividend of 2.50% for 2025–26, subject to a CAG audit and approval by members at the ensuing annual general meeting.
NLCIL is a public sector company engaged in lignite mining and power generation. NLCIL has diversified into renewable energy and coal mining businesses in India and abroad.
Its net profit stood at ₹61.12 crore in the year-ago period.
The total income rose to ₹1,195.22 crore in the January-March period of the last fiscal from ₹570.43 crore a year ago, according to a regulatory filing.
The company posted an exceptional gain of ₹1,267 crore during the fourth quarter of the last fiscal year.
During the 2025-26 fiscal year, the company's profit jumped to ₹1,094.64 crore from ₹101.2 crore in the preceding year.
Its total income rose to ₹2,778.85 crore in FY26 from ₹2,637.99 crore in 2024–25.
The company had posted a consolidated profit after tax (PAT) of ₹29.23 crore in the corresponding quarter of the previous fiscal year, Metropolis Healthcare Ltd said in a statement.
Consolidated revenue from operations in the fourth quarter of the previous fiscal year stood at ₹424.68 crore as compared to ₹345.29 crore in the year-ago period.
Total expenses in the quarter under review were higher at ₹363.19 crore as compared to ₹316.22 crore in the year-ago period, the company said.
The board has approved a second dividend of ₹1 per share for the 2025-26 financial year, it added.
The company had posted a consolidated net profit of ₹171.74 crore in the corresponding quarter of the previous fiscal year, Crompton Greaves Consumer Electricals Ltd said in a regulatory filing.
In the quarter that ended on March 31, 2026, the holding company acknowledged a loss of ₹716.04 crore on its investment in its important subsidiary Butterfly Gandhimathi Appliances Ltd (Butterfly) and the trademarks it bought on March 30, 2022, which reduced the value of goodwill and other related intangible assets, according to the filing.
Related News
About The Author

Next Story